Concepedia

Joshua K. Ochieng

JK

11

Publications

393

Citations

11

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Erasmus MC - Sophia Children’s Hospital

The University of Texas Health Science Center at Houston

Erasmus University Rotterdam

Erasmus MC

Joshua K. Ochieng is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and lung cancer.

ORCID

Top concepts

Publications per year

2013–2024

11

Publications

11

Sox2 Regulates the Emergence of Lung Basal Cells by Directly Activating the Transcription of <i>Trp63</i>

Joshua K. Ochieng, Kim Schilders, Heleen Kool et al. · American Journal of Respiratory Cell and Molecular Biology · 2014 · 94 citations

, , +23

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

David H. Peng, B. Leticia Rodriguez, Lixia Diao et al. · Nature Communications · 2021 · 64 citations · Full text

Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development

Warapen Treekitkarnmongkol, Maya Hassane, Ansam Sinjab et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 46 citations · Full text

Hypoxia Inducible Factor 3α Plays a Critical Role in Alveolarization and Distal Epithelial Cell Differentiation during Mouse Lung Development

Yadi Huang, Joshua K. Ochieng, Marjon Buscop-van Kempen et al. · PLoS ONE · 2013 · 35 citations · Full text

, , +22

Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

Jessica Konen, B. Leticia Rodriguez, Aparna Padhye et al. · Cancer Research · 2021 · 30 citations · Full text

Rows per page

1–5 of 11